Swiss National Bank cut its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 6.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 770,101 shares of the health services provider’s stock after selling 50,600 shares during the quarter. Swiss National Bank’s holdings in Cigna Group were worth $221,982,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA increased its stake in shares of Cigna Group by 1.1% in the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after purchasing an additional 123,479 shares in the last quarter. Dodge & Cox lifted its stake in shares of Cigna Group by 0.7% during the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock valued at $2,958,893,000 after buying an additional 60,877 shares in the last quarter. Norges Bank purchased a new stake in shares of Cigna Group during the 2nd quarter valued at approximately $1,110,426,000. Arrowstreet Capital Limited Partnership boosted its holdings in Cigna Group by 24.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after buying an additional 492,045 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in Cigna Group by 0.7% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock valued at $678,652,000 after buying an additional 15,014 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.
Cigna Group Stock Down 0.8%
Shares of NYSE:CI opened at $269.57 on Tuesday. The firm has a fifty day moving average price of $280.58 and a two-hundred day moving average price of $283.75. The company has a market cap of $71.04 billion, a price-to-earnings ratio of 12.15, a PEG ratio of 0.94 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a one year low of $239.51 and a one year high of $350.00.
Cigna Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is currently 28.13%.
Insider Activity
In other news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.70% of the company’s stock.
Wall Street Analysts Forecast Growth
CI has been the topic of a number of analyst reports. Sanford C. Bernstein reissued a “market perform” rating on shares of Cigna Group in a report on Wednesday, March 4th. Guggenheim reaffirmed a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Barclays dropped their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. Finally, Jefferies Financial Group raised their target price on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $330.42.
Get Our Latest Analysis on Cigna Group
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Buy this Gold Stock Before May 15th, 2026
- The Market Just Split in Two (URGENT)
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
